Core Immun. Lab for Assess. of AIDS Vaccines in Primates

Letvin, Norman L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research and Development Contracts (N01)
• Project #: N01AI035166-005
• Application #: 2295834
• Project Start: 1993-06-30
• Project End: 1998-06-29
• Budget Start: 1996-03-19
• Budget End: 1997-06-29
• Fiscal Year: 1996

Institution

• Name: Beth Israel Deaconess Medical Center
• DUNS #: 076593722
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02215

Publications

Robinson, H L (1997) DNA vaccines for immunodeficiency viruses. AIDS 11 Suppl A:S109-19

Lu, S; Manson, K; Wyand, M et al. (1997) SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups. Vaccine 15:920-3

Montefiori, D C; Reimann, K A; Letvin, N L et al. (1995) Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection. AIDS Res Hum Retroviruses 11:963-70

Montefiori, D C; Cornell, R J; Zhou, J Y et al. (1994) Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:82-92